TN2013000187A1 - Pharmaceutical composition, methods for treating and uses thereof - Google Patents

Pharmaceutical composition, methods for treating and uses thereof

Info

Publication number
TN2013000187A1
TN2013000187A1 TNP2013000187A TN2013000187A TN2013000187A1 TN 2013000187 A1 TN2013000187 A1 TN 2013000187A1 TN P2013000187 A TNP2013000187 A TN P2013000187A TN 2013000187 A TN2013000187 A TN 2013000187A TN 2013000187 A1 TN2013000187 A1 TN 2013000187A1
Authority
TN
Tunisia
Prior art keywords
treating
methods
pharmaceutical composition
type
diabetes mellitus
Prior art date
Application number
TNP2013000187A
Other languages
French (fr)
Inventor
Rolf Grempler
Odd-Erik Johansen
Thomas Klein
Gerd Luippold
Michael Mark
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2011/069532 external-priority patent/WO2012062698A1/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TN2013000187A1 publication Critical patent/TN2013000187A1/en

Links

Abstract

The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor and an insulin which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
TNP2013000187A 2011-11-07 2013-04-29 Pharmaceutical composition, methods for treating and uses thereof TN2013000187A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/069532 WO2012062698A1 (en) 2010-11-08 2011-11-07 Pharmaceutical composition, methods for treating and uses thereof

Publications (1)

Publication Number Publication Date
TN2013000187A1 true TN2013000187A1 (en) 2014-11-10

Family

ID=54360619

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000187A TN2013000187A1 (en) 2011-11-07 2013-04-29 Pharmaceutical composition, methods for treating and uses thereof

Country Status (1)

Country Link
TN (1) TN2013000187A1 (en)

Similar Documents

Publication Publication Date Title
PH12018500767A1 (en) Pharmaceutical composition, methods for treating and uses thereof
PH12016501607A1 (en) Sglt-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia
MX2013004699A (en) Pharmaceutical combinations for the treatment of metabolic disorders.
TN2011000415A1 (en) Pharmaceutical composition comprising a sglt2 inhibitor a dpp-i v inhibitor and optionally a further antidiabetic agent and uses thereof
PH12020500352A1 (en) Therapeutic uses of empagliflozin
UA100384C2 (en) Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative
MX2010001560A (en) Pharmaceutical composition comprising a sglt2 inhibitor in combination with a dpp-iv inhibitor.
EA201101187A1 (en) ANTI-DIABETIC MEDICINES CONTAINING DPP-4 INHIBITOR (LINAGLIPTIN) OPTIONAL IN COMBINATION WITH OTHER ANTI-DIABETIC MEANS
EP2217596B8 (en) Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
MX2015013948A (en) Therapeutic uses of empagliflozin.
WO2010029089A3 (en) Combination therapy for the treatment of diabetes and related conditions
TN2011000416A1 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
MX2009009417A (en) Piperidinyl-piperidine and piperazinyl-piperidine for use in the treatment of diabetes or pain.
PH12014502448A1 (en) Pharmaceutical combinations for the treatment of metabolic disorders
MX2012006734A (en) Ppar-sparing thiazolidinediones and combinations for the treatment of obesity and other metabolic diseases.
WO2008079610A3 (en) Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
NZ729455A (en) Compound having gpr119 agonistic activity, method for preparing the same, and pharmaceutical composition including the same as effective component
TN2013000187A1 (en) Pharmaceutical composition, methods for treating and uses thereof
WO2013188876A3 (en) Methods for modulating kallikrein (klkb1) expression
WO2014014816A3 (en) Methods of treating glucose metabolism disorders